SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-24-078891
Filing Date
2024-09-16
Accepted
2024-09-16 13:55:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM F-1 ea0214682-f1a2_altamira.htm F-1/A 394417
2 GRAPHIC image_001.jpg GRAPHIC 3516
3 GRAPHIC image_002.jpg GRAPHIC 2792
  Complete submission text file 0001213900-24-078891.txt   404754
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-281724 | Film No.: 241300686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)